Fig. 1From: Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancerThe study design, sample collections, and patients’ response. A Sample collection at different points. B Condition of enrolled patients. C Number of patients in different groups responding to pCRBack to article page